Related Experiment Videos
Exploring Diabetes Management Behaviours With FreeStyle Libre 2: Insights From Adults With Type 2 Diabetes in Quebec
Jean-François Yale1, Sylvie Bouchard2, Abraham Lee3
1McGill University, Montreal, Quebec, Canada.
Objective:
To understand the long-term behaviour changes associated with use of the FreeStyle Libre 2 sensor-based glucose monitor by people living with type 2 diabetes (T2D).
Methods:
This was a qualitative study of adults with T2D living in Quebec and using FreeStyle Libre 2. Discussions were moderated by an experienced facilitator using a semidirected discussion guide. Discussions were transcribed and analyzed thematically.
Results:
A total of 16 people living with T2D who had been using FreeStyle Libre 2 for >6 months participated in 2 focus groups (non-insulin treatments, 6 women and 3 men; basal insulin, 2 women and 5 men). No material differences in responses or anecdotes between the 2 groups were found. Use of FreeStyle Libre 2 was associated with the following 4 main themes: 1) personalized knowledge, including participants' sense of autonomy and control and their ability to see the effect of their actions on glucose levels and to make informed choices, such as modifying their diet; 2) improved communication with health-care providers, who can access patients' glucose data in real time if shared through the smartphone application; 3) reductions in hypoglycemia, particularly due to warnings of low glucose levels; and 4) long-term benefits, including reductions in stress and improved health-related quality of life.
Conclusions:
Long-term users found that FreeStyle Libre 2 improved their diabetes self-management, communication with health-care providers, health-related quality of life, and stress levels and facilitated lifestyle changes. Individuals with T2D described the device as empowering ongoing healthy behaviour change. This research serves as a person-centred qualitative finding to be considered in access decisions.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type II Diabetes II: Pathophysiology